Countercurrent, create the future | Shenzhen Cell Valley held 2024 full staff meeting in mid-year
At the meeting, Chairman Shi Yuanyuan gave a comprehensive and in-depth description of the enterprise from multiple dimensions, including the strategic development process of the enterprise, the construction and major breakthroughs of the enterprise, the current economic situation, and the work planning and core tasks of the second half of the year.
Enterprise strategy development process
In his speech, Chairman Shi Yuanyuan first made a comprehensive review of the company's development history. He pointed out that Shenzhen Cell Valley has firmly established its industry position in the domestic market and achieved steady development through the strategic layout carefully planned by the board of directors. In the process of internationalization, Shenzhen Cell Valley set up a wholly-owned subsidiary in Hong Kong, which laid a solid foundation for the expansion of the company to the Southeast Asian and North American markets, and strongly promoted the pace of the company's global development.
Enterprise construction and major breakthroughs
Subsequently, the chairman used rigorous data and tables to show the significant achievements and major breakthroughs in many aspects of the company's construction. The retention rate of interns is as high as 75%, which reflects the effectiveness of the company's talent strategy, the timely adjustment of the company's organizational structure, which provides a strong guarantee for the efficient operation of the company, and the appointment of an internationally renowned medical doctor as the chief medical consultant has further enhanced the company's professional level and international influence
In particular, the product pipeline of Shenzhen Cell Valley is showing a booming trend, and the product line is increasingly rich and improving. In the field of independent research and development projects, the company has made remarkable breakthroughs, successfully realized the innovation of Human NK cell cryopreservation technology, and actively promoted the development of Mouse NK cells and the establishment of eVLP delivery platform. At the same time, the company has also made significant progress in the optimization of γδT cells and BaEV transduction, which has laid a solid foundation for the company's leading position in the field of cell therapy. With the unremitting spirit of innovation, the R&D technical team of Shenzhen Cell Valley has successfully created a new situation of off-the-shelf cell products and injected new vitality into the development of the company. In terms of CRO projects, the company has cooperated with a number of domestic public third-class hospitals and made important breakthroughs in a number of projects, which indicates that the company's professional ability and service quality in the field of CRO have been widely recognized by the industry.
Current economic situation
Chairman Shi Yuan clearly pointed out in his elaboration that the biomedical industry is facing multiple serious challenges, including the significant height of the technical threshold, the long-term nature of the return cycle and the great difficulty in manufacturing quality control. In view of the severity of the current economic situation, the general depreciation of major types of assets, and the serious impact on market confidence, Shenzhen Cell Valley, as a technology-driven enterprise, shows unique resilience and determination, closely tracking the latest developments in the international biomedical field, upstream, and firmly toward the goal of becoming one of the leading CGT companies in China.
Work planning and core tasks for the second half of the year
In view of the goals and priorities of the second half of the year, Chairman Shi Yuanyuan clearly put forward four requirements in order to ensure the smooth promotion of the company's overall strategy and the successful achievement of the annual target. First of all, at the goal-oriented level, the chairman stressed that all employees should have firm faith, closely focus on the annual target, and highly focus on the core tasks. Each employee should establish the determination to win and have the courage to face challenges to ensure that the target can be successfully achieved. Secondly, in terms of strategic planning, the chairman pointed out that it is necessary to continuously increase efforts in key areas such as project initiation, honor acquisition and international cooperation. At the same time, full attention should be paid to the development of the international market to promote the in-depth implementation of the company's globalization strategy. At the internal management level, the chairman asked the leaders of all departments to clarify their work ideas and ensure that all work is carried out around the established goals. The company will establish and improve the performance appraisal mechanism, reward and punishment, effective incentive, so that the value of every cell Valley can be maximized. Finally, in terms of operation and management, the chairman stressed that all project approval and resource allocation should be carried out closely around market demand, and the company should continue to pay attention to market dynamics, timely adjust business strategies, and ensure that resources are tilted to high-benefit areas to maximize the company's economic benefits.
In the second half of 2024, under the guidance of Chairman Shi Yuan, Shenzhen Cell Valley will closely focus on the core tasks and go all out to promote the orderly development of various works. In the context of this industry with both challenges and opportunities, "Bloom in the winter, rise in adversity!" We firmly believe that only after experiencing the baptism of cold, can bloom more brilliant brilliance; Only in the face of adversity, can we achieve a more brilliant rise. Shenzhen Cell Valley will join hands with all employees to write a brilliant chapter of our own!
